tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SRPT is currently covered by 28 analysts with an average price target of $36.97. This is a potential upside of $19.52 (111.86%) from yesterday's end of day stock price of $17.45.
Sarepta Therapeutics's activity chart (see below) currently has 861 price targets and 741 ratings on display. The stock rating distribution of SRPT is 53.51% BUY, 10.53% SELL and 35.96% HOLD.
Analysts average stock forecasts to be materialized ratio is 52.32% with an average time for these price targets to be met of 235.4 days.
Highest price target for SRPT is $80, Lowest price target is $5, average price target is $24.37.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 27-Feb-2026. First documented stock forecast 20-Mar-2013.
Currently out of the existing stock ratings of SRPT, 61 are a BUY (53.51%), 12 are a SELL (10.53%), 41 are a HOLD (35.96%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Apr-2025
$38
$20.55 (117.77%)
$45
2 days ago
(27-Feb-2026)
0/8 (0%)
$20.55 (117.77%)
Sell Since 25-Aug-2025
$5
$-12.45 (-71.35%)
$5
1 months 2 days ago
(27-Jan-2026)
8/13 (61.54%)
$-17.17 (-77.45%)
55
Buy Since 14-Jun-2021
$34
$16.55 (94.84%)
$160
1 months 6 days ago
(23-Jan-2026)
7/9 (77.78%)
$12.87 (60.91%)
275
Buy Since 01-Nov-2019
$19
$1.55 (8.88%)
$98
3 months 24 days ago
(05-Nov-2025)
4/7 (57.14%)
$0.33 (1.77%)
210
Hold Since 04-Nov-2025
$15
$-2.45 (-14.04%)
$35
3 months 25 days ago
(04-Nov-2025)
41/61 (67.21%)
$-1.2 (-7.41%)
290
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?
